Evaluation of diagnostic imaging technologies and therapeutics devices: Better information for better decisions. Proceedings of a multidisciplinary workshop

American Heart Journal

Volumn 152, Issue 1, 2006, Pages 50-58

  Califf, Robert M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; BUDGET; COST; DIAGNOSTIC IMAGING; ENVIRONMENT; FOOD AND DRUG ADMINISTRATION; HEALTH SERVICE; HUMAN; LIFE CYCLE; MEDICAID; MEDICAL DECISION MAKING; MEDICAL INSTRUMENTATION; MEDICARE; METHODOLOGY; MOLECULAR IMAGING; PHYSICIAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK; SUDDEN DEATH; TECHNOLOGY;

EID: 33745645232     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.10.001     Document Type: Note

References (36)

1. US Census Bureau. National population projections. Available at:. http://www.census.gov/population/www/projections/natproj.html [Accessed 30 September 2004]
2. Baicker K., and Chandra A. Medicare spending, the physician workforce, and beneficiaries' quality of care. Health Aff W4 (2004) 184-197
3. Tunis S.R., Stryer D.B., and Clancy C.M. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290 (2003) 1624-1632
4. Leiner S., Chatterton H.T., Punglia R.S., et al. Verification bias in screening for prostate cancer. N Engl J Med 349 (2003) 1672-1673
5. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003) 2059-2073
6. Wagner R.F., Beiden S.V., Campbell G., et al. Assessment of medical imaging and computer-assist systems: lessons from recent experience. Acad Radiol 9 (2002) 1264-1277
7. Sung N.S., Crowley Jr. W.F., Genel M., et al. Central challenges facing the national clinical research enterprise. JAMA 289 (2003) 1278-1287
8. Kimbell J.J. A wake-up call to device entrepreneurs. Med Device Diagn Ind (1996) 24-40
9. O'Shea J.C., Kramer J.M., Califf R.M., et al. Sharing a commitment to improve cardiovascular devices-part 1: identifying holes in the safety net. Am Heart J 147 (2004) 977-984
10. Shah M.R., O'Connor C.M., Sopko G., et al. Evaluation Study of Congestive heart failure And Pulmonary artery catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J 141 (2001) 528-535
11. Peterson E.D., Kaul P., Kaczmarek R.G., et al., for the Society of Thoracic Surgeons. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol 42 (2003) 1611-1616
12. Hakama M., Stenman U.H., Aromaa A., et al. Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland. J Urol 166 (2001) 2189-2192
13. Crowley Jr. W.F., Sherwood L., Salber P., et al. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. JAMA 291 (2004) 1120-1126
14. Kupersmith J. The past, present, and future of the implantable cardioverter defibrillator. Am J Med 113 (2002) 82-84
15. Lee K.L., Hafley G., Fisher J.D., et al., for the Multicenter Unsustained Tachycardia Trial Investigators. Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation 106 (2002) 233-238
16. Centers for Medicare and Medicaid Services. Available at:. http://www.cms.hhs.gov/manuals/06_cim/R173FlowChart.pdf. [Accessed 30 September 2004]
17. Al Khatib S., Sanders G.D., Mark D.B., et al. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 149 (2005) 1020-1034
18. Lamont D.H., Budoff M.J., Shavelle D.M., et al. Coronary calcium scanning adds incremental value to patients with positive stress tests. Am Heart J 143 (2002) 861-867
19. O'Malley P.G., Greenberg B.A., and Taylor A.J. Cost-effectiveness of using electron beam computed tomography to identify patients at risk for clinical coronary artery disease. Am Heart J 148 (2004) 106-113
20. U.S. Preventive Services Task Force. Screening for coronary heart disease: recommendation statement. Ann Intern Med 140 (2004) 569-572
21. British Columbia Office of Health Technology Assessment (BCOHTA). Incorporating clinical effectiveness debates into hospital technology assessment: the case of laser treatment of benign prostatic hyperplasia. Int J Technol Assess Health Care 13 (1997) 937-939
22. Gross R., and Strom B.L. Toward improved adverse event/suspected adverse drug reaction reporting. Pharmacoepidemiol Drug Saf 12 (2003) 89-91
23. Cutlip D.E., Leon M.B., Ho K.K., et al. Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. J Am Coll Cardiol 34 (1999) 698-706
24. Kerlikowske K., Grady D., Rubin S.M., et al. Efficacy of screening mammography: a meta-analysis. JAMA 273 (1995) 149-154
25. Minoshima S., Frey K.A., Cross D.J., et al. Neurochemical imaging of dementias. Semin Nuclear Med 34 (2004) 70-82
26. Clancy C.M. Carolyn M. Clancy, MD, Director, Agency for Healthcare Research and Quality. J Investig Med 52 (2004) 77-80
27. Kulynych J., and Korn D. The new HIPAA (Health Insurance Portability and Accountability Act of 1996) Medical Privacy Rule: help or hindrance for clinical research?. Circulation 108 (2003) 912-914
28. Califf R.M., and Muhlbaier L.H. Health Insurance Portability and Accountability Act (HIPAA): must there be a trade-off between privacy and quality of health care, or can we advance both?. Circulation 108 (2003) 915-918
29. Zerhouni E. The NIH Roadmap. Science 302 (2003) 63-72
30. Tilson H., Helms D., and Dowdy D. Improving the US health care system: action plan to enhance efficiency, reduce errors, and improve quality. J Investig Med 51 (2003) 72-78
31. Peterson E.D., Coombs L.P., DeLong E.R., et al. Procedural volume as a marker of quality for CABG surgery. JAMA 291 (2004) 195-201
32. O'Malley A.J., Normand S.L., and Kuntz R.E. Application of models for multivariate mixed outcomes to medical device trials: coronary artery stenting. Stat Med 22 (2003) 313-336
33. Concato J., Shah N., and Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342 (2000) 1887-1892
34. Yusuf S., Wittes J., and Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 260 (1988) 2088-2093
35. Califf R.M. Defining the balance of risk and benefit in the era of genomics and proteomics. Health Aff 23 (2004) 77-87
36. Wang S.S., Mendelson D.N., Schulman K.A., et al. Exploring options for improving healthcare. Am Heart J 147 (2004) 23-30